Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CSNK1E |
| Upstream (Parents) |
|---|
| (<<) CDR2 → CSNK1E |
| (<<) CLCF1 → CSNK1E |
| (<<) CXCL2 → CSNK1E |
| (<<) CYP1A2 → CSNK1E |
| (<<) DUSP1 → CSNK1E |
| (<<) DYNLL1 → CSNK1E |
| (<<) ELOVL1 → CSNK1E |
| (<<) ENO2 → CSNK1E |
| (<<) HSD11B1 → CSNK1E |
| (<<) PAK1 → CSNK1E |
| (<<) S100P → CSNK1E |
| Downstream (Children) |
|---|
| CSNK1E → ABLIM1 (>>) |
| CSNK1E → DNM2 (>>) |
| CSNK1E → DYRK1A (>>) |
| CSNK1E → E2F2 (>>) |
| CSNK1E → INPPL1 (>>) |
| CSNK1E → LIPG (>>) |
| CSNK1E → PELO (>>) |
| CSNK1E → PPP1R11 (>>) |
| CSNK1E → PPP2R5C (>>) |
| CSNK1E → PTPN11 (>>) |
| CSNK1E → SOS2 (>>) |
| CSNK1E → VANGL1 (>>) |
